A comparison of 4-hydroxycholesterol:cholesterol and 6-hydroxycortisol:cortisol as markers of CYP3A4 induction

被引：37
作者：
Arrhen, Yvonne Marde [1 ]
Nylen, Hanna [2 ]
Lovgren-Sandblom, Anita [2 ]
Kanebratt, Kajsa P. [3 ]
Wide, Katarina [4 ]
Diczfalusy, Ulf [2 ]
机构：
[1] Karolinska Univ Hosp, Huddinge, Sweden
[2] Karolinska Inst, Dept Lab Med, Huddinge, Sweden
[3] AstraZeneca R&D, CVGI IMed DMPK, Molndal, Sweden
[4] Karolinska Inst, Dept CLINTEC, Huddinge, Sweden
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 75卷 / 06期
基金：
瑞典研究理事会;
关键词：
CYP3A4; endogenous markers; induction; LC-MS; MS; rifampicin; ENDOGENOUS MARKER; 4-BETA-HYDROXYCHOLESTEROL; HUMANS; 6-BETA-HYDROXYCORTISOL; INHIBITION; RIFAMPICIN;
D O I：
10.1111/bcp.12016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aim To compare plasma 4-hydroxycholesterol:cholesterol with urinary 6-hydroxycortisol:cortisol as markers of cytochrome P4503A4 activity before and after treatment with rifampicin for 2 weeks. Method 6-hydroxycortisol and cortisol were determined by liquid chromatography tandem mass spectrometry and 4-hydroxycholesterol was determined by gas chromatographymass spectrometry in three groups of healthy volunteers. Results Induction ratios for 6-hydroxycortisol:cortisol were 1.8, 3.9 and 4.5 for 20mgday1, 100mgday1 or 500mgday1 of rifampicin, respectively. The corresponding ratios for 4-hydroxycholesterol:cholesterol were 1.5, 2.4 and 3.8. Conclusions Plasma 4-hydroxycholesterol:cholesterol gave similar induction ratios to urinary 6-hydroxycortisol:cortisol.
引用
收藏
页码：1536 / 1540
页数：5
相关论文
共 7 条
  • [1] Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans -: Evidence for involvement of cytochrome P450 3A4
    Bodin, K
    Bretillon, L
    Aden, Y
    Bertilsson, L
    Broomé, U
    Einarsson, C
    Diczfalusy, U
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38685 - 38689
  • [2] 4β-Hydroxycholesterol is a new endogenous CYP3A marker:: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians
    Diczfalusy, Ulf
    Miura, Jun
    Roh, Hyung-Keun
    Mirghani, Rajaa A.
    Sayi, Jane
    Larsson, Hanna
    Bodin, Karl G.
    Allqvist, Annika
    Jande, Mary
    Kim, Jong-Wook
    Aklillu, Eleni
    Gustafsson, Lars L.
    Bertilsson, Leif
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (03) : 201 - 208
  • [3] 4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
    Diczfalusy, Ulf
    Nylen, Hanna
    Elander, Pontus
    Bertilsson, Leif
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 183 - 189
  • [4] 4β-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin
    Diczfalusy, Ulf
    Kanebratt, Kajsa P.
    Bredberg, Eva
    Andersson, Tommy B.
    Bottiger, Ylva
    Bertilsson, Leif
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (01) : 38 - 43
  • [5] Urinary 6β-hydroxycortisol:: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals
    Galteau, MM
    Shamsa, F
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (10) : 713 - 733
  • [6] Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol
    Kanebratt, K. P.
    Diczfalusy, U.
    Backstrom, T.
    Sparve, E.
    Bredberg, E.
    Bottiger, Y.
    Andersson, T. B.
    Bertilsson, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (05) : 589 - 594
  • [7] Evaluation of 6β-Hydroxycortisol, 6β-Hydroxycortisone, and a Combination of the Two as Endogenous Probes for Inhibition of CYP3A4 In Vivo
    Peng, C-C
    Templeton, I.
    Thummel, K. E.
    Davis, C.
    Kunze, K. L.
    Isoherranen, N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 888 - 895
1